This will be important for the target validation with the identification of gene-sets in correlation with NRP1 and NRP2 which can work as biomarkers for cancer diagnosis and prognosis as therapeutic targets to reprogram TAMs and disrupt their pro-tumorigenic functions. The gene discussed is NRP2; the disease is cancer.